ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.23%
S&P ASX All Technology
2,972.40
0.12%
Brent Oil
84.195
0.78%
US Dollar vs AUD
1.53156
0.04%
Bitcoin
59,055.86
1.40%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NewAmsterdam Pharma Company NV (NAMSW)

  7. NewAmsterdam Pharma Company NV (NAMSW) News

NAMSW NewAmsterdam Pharma Company NV

9.7301
0.00 (0.00%)
Pre Market
Last Updated: 10:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
NewAmsterdam Pharma Company NV NAMSW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.00 0.00% 9.7301 10:00:00
Open Price Low Price High Price Close Price Previous Close
9.7301
more quote information »

Recent News

Date Time Source Heading
02/5/202422:00GLOBENewAmsterdam Pharma to Host R&D Day with Key Opinion Leaders..
09/4/202422:00GLOBENewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal..
01/4/202423:00GLOBENewAmsterdam Pharma Announces the Appointment of Juliette..
25/3/202423:00GLOBENewAmsterdam Pharma to Present New Analysis from the Phase 2..
12/3/202423:00GLOBENewAmsterdam Pharma Doses First Patient in Phase 3 TANDEM..
29/2/202400:00GLOBENewAmsterdam Pharma Reports Full Year 2023 Financial Results..
27/2/202400:00GLOBENewAmsterdam Pharma to Participate in Upcoming Investor..
14/2/202414:40GLOBENewAmsterdam Pharma Announces Pricing of $175.3 Million..
14/2/202408:01GLOBENewAmsterdam Pharma Announces Commencement of Public..
02/2/202408:01GLOBENewAmsterdam Pharma to Present at Guggenheim Healthcare..
09/1/202400:00GLOBENewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A...
05/1/202400:00GLOBENewAmsterdam Pharma Announces 2024 Strategic Priorities
14/11/202300:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
23/10/202323:00GLOBENewAmsterdam Pharma Announces Appointment of Ian Somaiya as..
21/9/202321:00GLOBENewAmsterdam Pharma Announces Initial Data from Phase 2a..
20/9/202322:00GLOBENewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald..
15/8/202306:01GLOBENewAmsterdam Pharma Announces Appointment of William “BJ”..
07/8/202321:15GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..
26/7/202306:01GLOBENewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3..
10/6/202306:01GLOBENewAmsterdam Pharma Announces Closing of Upsized Secondary..
07/6/202313:25GLOBENewAmsterdam Pharma Announces Pricing of Upsized Secondary..
07/6/202306:01GLOBENewAmsterdam Pharma Announces Commencement of Secondary..
05/6/202321:00GLOBENewAmsterdam Pharma Announces Positive Topline Results from..
04/6/202302:15GLOBENewAmsterdam Pharma Presents Full Data from Phase 2 ROSE2..
31/5/202322:00GLOBENewAmsterdam Pharma to Present at Jefferies Healthcare..
23/5/202322:00GLOBENewAmsterdam to Present Full Data from ROSE2 at NLA..
08/5/202322:00GLOBENewAmsterdam Pharma Provides Corporate Update and Reports..

Your Recent History

NASDAQ
NAMSW
NewAmsterdam Pharma Comp...
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved